It sounds like the 3rd party testing has been very successful and GenUltimate! TBG is ready to move into clinical trials. I'm looking forward to seeing how KB moves the ball forward. With accuracy numbers as good as +/- 7.5%, there should be a lot of interested parties.
(0)
(0)
Decision Diagnostics Corp (DECN) Stock Research Links